American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

Recruiting now NCT02674100

Run by University of Louisville · for 18 and older · All sexes

What this study is about

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.

Who can join (things the study team will check)

✅ You may be able to join if…

Adult patients (greater than 18 years of age) diagnosed with pancreatic cancer that are eligible for soft tissue ablation per the treating physician.

🚫 You may not be able to join if…

Have a cardiac pacemaker or ICD implant
Non-removable implants with metal parts near target lesion
Myocardial infarction within 3 months prior to enrollment
Not suitable for general endotracheal anesthesia

Where this trial is running

University of Alabama Birmingham, Birmingham, Alabama, United States
University of California San Diego, San Diego, California, United States
University of Colorado, Denver, Colorado, United States
University of South Florida, Tampa, Florida, United States
Augusta University, Augusta, Georgia, United States
University of Louisville, Louisville, Kentucky, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States
Atlantic Health, Millburn, New Jersey, United States
Northwell Health Cancer Institute, Lake Success, New York, United States
Gibbs Cancer Research, Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States
Methodist Digestive Institute, Dallas, Texas, United States
McGill University, Montreal, Quebec, Canada

+ 4 more sites.

Who to contact

Robert Martin, MD, PhD · 502-629-3355 · robert.martin@louisville.edu

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT02674100.

Open the interactive checklist for this trial →

Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.

Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.